Sumitomo Pharma Co., Ltd.
CIK 0001446601 Name as filed on the most recent filing
Filed as Sumitomo Pharma Co., Ltd. (2)· Dainippon Sumitomo Pharma Co Ltd (42)
94 transaction lines · from 44 filings · filed 2020-02-21 to 2023-06-26 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
- ISSUER Roivant Sciences Ltd. 1 filings
- ISSUER Myovant Sciences Ltd. 42 filings
- ISSUER Urovant Sciences Ltd. 1 filings
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
0 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2023-06-22 |
Roivant Sciences Ltd. ROIV |
S, Open-market sale | 15,116,277 disposed | 8.60 | 129,999,982.20 | Form 4, filing 0000899243-23-016487 | |
| 2023-03-10 |
Myovant Sciences Ltd. MYOV |
P, Open-market purchase | 51,599,200 acquired | 27.00 | 1,393,178,400.00 | Form 4, filing 0000899243-23-007864 | |
| 2021-09-28 |
Myovant Sciences Ltd. MYOV |
P, Open-market purchase | 20,677 acquired | 22.85 | 472,382.61 | Form 4, filing 0000899243-21-038387 | |
| 2021-09-27 |
Myovant Sciences Ltd. MYOV |
P, Open-market purchase | 45,768 acquired | 24.19 | 1,106,903.66 | Form 4, filing 0000899243-21-038083 | |
| 2021-09-27 |
Myovant Sciences Ltd. MYOV |
P, Open-market purchase | 2,232 acquired | 24.86 | 55,486.18 | Form 4, filing 0000899243-21-038083 | |
| 2021-09-24 |
Myovant Sciences Ltd. MYOV |
P, Open-market purchase | 36,000 acquired | 23.40 | 842,547.60 | Form 4, filing 0000899243-21-038083 | |
| 2021-09-23 |
Myovant Sciences Ltd. MYOV |
P, Open-market purchase | 49,467 acquired | 23.01 | 1,138,468.16 | Form 4, filing 0000899243-21-037631 | |
| 2021-09-23 |
Myovant Sciences Ltd. MYOV |
P, Open-market purchase | 5,311 acquired | 23.49 | 124,747.42 | Form 4, filing 0000899243-21-037631 | |
| 2021-09-22 |
Myovant Sciences Ltd. MYOV |
P, Open-market purchase | 84,018 acquired | 21.96 | 1,845,010.07 | Form 4, filing 0000899243-21-037631 | |
| 2021-09-21 |
Myovant Sciences Ltd. MYOV |
P, Open-market purchase | 43,000 acquired | 22.48 | 966,450.80 | Form 4, filing 0000899243-21-037114 | |
| 2021-09-20 |
Myovant Sciences Ltd. MYOV |
P, Open-market purchase | 38,273 acquired | 22.10 | 845,668.73 | Form 4, filing 0000899243-21-037114 | |
| 2021-09-17 |
Myovant Sciences Ltd. MYOV |
P, Open-market purchase | 37,913 acquired | 22.79 | 864,105.51 | Form 4, filing 0000899243-21-036597 | |
| 2021-09-16 |
Myovant Sciences Ltd. MYOV |
P, Open-market purchase | 50,000 acquired | 21.75 | 1,087,550.00 | Form 4, filing 0000899243-21-036597 | |
| 2021-09-15 |
Myovant Sciences Ltd. MYOV |
P, Open-market purchase | 89,864 acquired | 21.98 | 1,975,489.30 | Form 4, filing 0000899243-21-036290 | |
| 2021-09-14 |
Myovant Sciences Ltd. MYOV |
P, Open-market purchase | 65,128 acquired | 22.04 | 1,435,238.76 | Form 4, filing 0000899243-21-036290 | |
| 2021-09-14 |
Myovant Sciences Ltd. MYOV |
P, Open-market purchase | 6,172 acquired | 22.76 | 140,446.95 | Form 4, filing 0000899243-21-036290 | |
| 2021-09-13 |
Myovant Sciences Ltd. MYOV |
P, Open-market purchase | 53,150 acquired | 23.09 | 1,227,058.10 | Form 4, filing 0000899243-21-035821 | |
| 2021-09-13 |
Myovant Sciences Ltd. MYOV |
P, Open-market purchase | 30,028 acquired | 23.91 | 717,990.50 | Form 4, filing 0000899243-21-035821 | |
| 2021-09-10 |
Myovant Sciences Ltd. MYOV |
P, Open-market purchase | 30,000 acquired | 25.11 | 753,390.00 | Form 4, filing 0000899243-21-035821 | |
| 2021-09-09 |
Myovant Sciences Ltd. MYOV |
P, Open-market purchase | 37,000 acquired | 25.52 | 944,147.50 | Form 4, filing 0000899243-21-035564 | |
| 2021-09-08 |
Myovant Sciences Ltd. MYOV |
P, Open-market purchase | 21,902 acquired | 25.74 | 563,663.30 | Form 4, filing 0000899243-21-035564 | |
| 2021-09-07 |
Myovant Sciences Ltd. MYOV |
P, Open-market purchase | 28,287 acquired | 26.08 | 737,679.70 | Form 4, filing 0000899243-21-035342 | |
| 2021-09-07 |
Myovant Sciences Ltd. MYOV |
P, Open-market purchase | 4,913 acquired | 27.12 | 133,249.40 | Form 4, filing 0000899243-21-035342 | |
| 2021-09-03 |
Myovant Sciences Ltd. MYOV |
P, Open-market purchase | 29,822 acquired | 26.74 | 797,383.62 | Form 4, filing 0000899243-21-035342 | |
| 2021-09-03 |
Myovant Sciences Ltd. MYOV |
P, Open-market purchase | 1,378 acquired | 27.29 | 37,609.89 | Form 4, filing 0000899243-21-035342 | |
| 2021-09-02 |
Myovant Sciences Ltd. MYOV |
P, Open-market purchase | 35,045 acquired | 26.46 | 927,388.83 | Form 4, filing 0000899243-21-035135 | |
| 2021-09-02 |
Myovant Sciences Ltd. MYOV |
P, Open-market purchase | 22,209 acquired | 25.25 | 560,872.75 | Form 4, filing 0000899243-21-035135 | |
| 2021-09-02 |
Myovant Sciences Ltd. MYOV |
P, Open-market purchase | 5,848 acquired | 26.95 | 157,631.09 | Form 4, filing 0000899243-21-035135 | |
| 2021-09-01 |
Myovant Sciences Ltd. MYOV |
P, Open-market purchase | 40,000 acquired | 24.83 | 993,028.00 | Form 4, filing 0000899243-21-035135 | |
| 2021-08-31 |
Myovant Sciences Ltd. MYOV |
P, Open-market purchase | 39,000 acquired | 24.28 | 946,884.90 | Form 4, filing 0000899243-21-034765 | |
| 2021-08-30 |
Myovant Sciences Ltd. MYOV |
P, Open-market purchase | 70,000 acquired | 23.92 | 1,674,099.00 | Form 4, filing 0000899243-21-034765 | |
| 2021-08-27 |
Myovant Sciences Ltd. MYOV |
P, Open-market purchase | 37,038 acquired | 23.17 | 858,251.94 | Form 4, filing 0000899243-21-034525 | |
| 2021-08-26 |
Myovant Sciences Ltd. MYOV |
P, Open-market purchase | 40,000 acquired | 22.67 | 906,912.00 | Form 4, filing 0000899243-21-034525 | |
| 2021-08-25 |
Myovant Sciences Ltd. MYOV |
P, Open-market purchase | 28,709 acquired | 22.44 | 644,158.19 | Form 4, filing 0000899243-21-034281 | |
| 2021-08-24 |
Myovant Sciences Ltd. MYOV |
P, Open-market purchase | 34,299 acquired | 22.37 | 767,268.63 | Form 4, filing 0000899243-21-034281 | |
| 2021-08-23 |
Myovant Sciences Ltd. MYOV |
P, Open-market purchase | 30,390 acquired | 22.45 | 682,322.36 | Form 4, filing 0000899243-21-034046 | |
| 2021-08-23 |
Myovant Sciences Ltd. MYOV |
P, Open-market purchase | 25,057 acquired | 22.13 | 554,413.69 | Form 4, filing 0000899243-21-034046 | |
| 2021-08-20 |
Myovant Sciences Ltd. MYOV |
P, Open-market purchase | 46,478 acquired | 20.86 | 969,540.38 | Form 4, filing 0000899243-21-034046 | |
| 2021-08-19 |
Myovant Sciences Ltd. MYOV |
P, Open-market purchase | 46,792 acquired | 21.51 | 1,006,421.05 | Form 4, filing 0000899243-21-033840 | |
| 2021-08-18 |
Myovant Sciences Ltd. MYOV |
P, Open-market purchase | 17,116 acquired | 21.45 | 367,091.99 | Form 4, filing 0000899243-21-033840 | |
| 2021-08-17 |
Myovant Sciences Ltd. MYOV |
P, Open-market purchase | 23,549 acquired | 20.89 | 492,049.29 | Form 4, filing 0000899243-21-033476 | |
| 2021-08-16 |
Myovant Sciences Ltd. MYOV |
P, Open-market purchase | 42,785 acquired | 21.29 | 911,055.23 | Form 4, filing 0000899243-21-033476 | |
| 2021-08-16 |
Myovant Sciences Ltd. MYOV |
P, Open-market purchase | 5,382 acquired | 21.94 | 118,089.69 | Form 4, filing 0000899243-21-033476 | |
| 2020-05-20 |
Myovant Sciences Ltd. MYOV |
P, Open-market purchase | 37,897 acquired | 12.58 | 476,861.74 | Form 4, filing 0000899243-20-013825 | |
| 2020-05-19 |
Myovant Sciences Ltd. MYOV |
P, Open-market purchase | 50,000 acquired | 12.10 | 605,050.00 | Form 4, filing 0000899243-20-013825 | |
| 2020-05-18 |
Myovant Sciences Ltd. MYOV |
P, Open-market purchase | 35,000 acquired | 12.36 | 432,624.50 | Form 4, filing 0000899243-20-013546 | |
| 2020-05-15 |
Myovant Sciences Ltd. MYOV |
P, Open-market purchase | 49,812 acquired | 12.12 | 603,965.52 | Form 4, filing 0000899243-20-013546 | |
| 2020-05-14 |
Myovant Sciences Ltd. MYOV |
P, Open-market purchase | 50,000 acquired | 12.02 | 600,760.00 | Form 4, filing 0000899243-20-013205 | |
| 2020-05-13 |
Myovant Sciences Ltd. MYOV |
P, Open-market purchase | 41,331 acquired | 12.38 | 511,640.58 | Form 4, filing 0000899243-20-013205 | |
| 2020-05-12 |
Myovant Sciences Ltd. MYOV |
P, Open-market purchase | 24,448 acquired | 13.51 | 330,404.94 | Form 4, filing 0000899243-20-013027 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
- P, Open-market purchase
- Open-market purchase
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.
How to cite this page
ebomi catalog. Sumitomo Pharma Co., Ltd., insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001446601
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6